| 0 |
COMPLEMENT FACTOR |
2 |
0.6667 |
| 1 |
IMMUNE EFFECTOR CELL ENCEPHALOPATHY SCORE |
4 |
0.4444 |
| 2 |
MALIGNANT GENITOURINARY TRACT NEOPLASM |
12 |
0.1791 |
| 3 |
MEDULLARY COMPRESSION SYNDROME |
2 |
0.1667 |
| 4 |
IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY |
18 |
0.1034 |
| 5 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
604 |
0.1019 |
| 6 |
MANTLE CELL LYMPHOMA REFRACTORY |
6 |
0.0909 |
| 7 |
MANTLE CELL LYMPHOMA RECURRENT |
36 |
0.0828 |
| 8 |
LYMPHOCYTE ADOPTIVE THERAPY |
22 |
0.0789 |
| 9 |
ACUTE ERYTHROID LEUKAEMIA |
4 |
0.0635 |
| 10 |
CELL-MEDIATED CYTOTOXICITY |
3 |
0.0588 |
| 11 |
CD19 LYMPHOCYTES INCREASED |
1 |
0.0588 |
| 12 |
IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME |
8 |
0.0530 |
| 13 |
CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE |
1 |
0.0476 |
| 14 |
CYTOKINE RELEASE SYNDROME |
938 |
0.0467 |
| 15 |
ALVEOLAR RHABDOMYOSARCOMA |
2 |
0.0455 |
| 16 |
LEUKAPHERESIS |
1 |
0.0455 |
| 17 |
LISTERAEMIA |
1 |
0.0400 |
| 18 |
ANAL SQUAMOUS CELL CARCINOMA |
12 |
0.0390 |
| 19 |
GENITOURINARY TRACT NEOPLASM |
3 |
0.0361 |
| 20 |
MENINGITIS EOSINOPHILIC |
1 |
0.0333 |
| 21 |
B-CELL APLASIA |
8 |
0.0310 |
| 22 |
HERPES ZOSTER REACTIVATION |
8 |
0.0305 |
| 23 |
LYMPHODEPLETION |
1 |
0.0294 |
| 24 |
MANTLE CELL LYMPHOMA |
37 |
0.0243 |
| 25 |
IGG DEFICIENCY |
1 |
0.0233 |
| 26 |
INFECTIOUS DISEASE CARRIER |
1 |
0.0213 |
| 27 |
INTENSIVE CARE UNIT DELIRIUM |
1 |
0.0208 |
| 28 |
APHERESIS |
1 |
0.0200 |
| 29 |
MASTOID EFFUSION |
1 |
0.0200 |
| 30 |
TRAUMATIC LUMBAR PUNCTURE |
1 |
0.0196 |
| 31 |
GLIONEURONAL TUMOUR |
1 |
0.0185 |
| 32 |
ALANINE AMINOTRANSFERASE |
4 |
0.0181 |
| 33 |
LACK OF CONCOMITANT DRUG EFFECT |
1 |
0.0175 |
| 34 |
TRANSDIFFERENTIATION OF NEOPLASM |
1 |
0.0172 |
| 35 |
HYPOFIBRINOGENAEMIA |
17 |
0.0171 |
| 36 |
BACTEROIDES BACTERAEMIA |
1 |
0.0167 |
| 37 |
MANTLE CELL LYMPHOMA STAGE IV |
1 |
0.0167 |
| 38 |
GRAFT VERSUS HOST DISEASE ORAL |
1 |
0.0156 |
| 39 |
ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY |
2 |
0.0148 |
| 40 |
SCROTAL PAIN |
8 |
0.0148 |
| 41 |
DIVERTICULITIS INTESTINAL PERFORATED |
5 |
0.0140 |
| 42 |
BLOOD BRAIN BARRIER DEFECT |
2 |
0.0132 |
| 43 |
SQUAMOUS CELL CARCINOMA OF SKIN |
75 |
0.0124 |
| 44 |
NEUROTOXICITY |
202 |
0.0115 |
| 45 |
ENTEROVIRUS TEST POSITIVE |
2 |
0.0115 |
| 46 |
ANTITHROMBIN III DEFICIENCY |
1 |
0.0112 |
| 47 |
IMMUNE-MEDIATED ENCEPHALOPATHY |
1 |
0.0112 |
| 48 |
MORAXELLA INFECTION |
3 |
0.0109 |
| 49 |
NATURAL KILLER CELL COUNT DECREASED |
1 |
0.0109 |
| 50 |
VISUAL FIELD TESTS ABNORMAL |
1 |
0.0108 |
| 51 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
3 |
0.0106 |
| 52 |
ADENOVIRUS TEST POSITIVE |
1 |
0.0105 |
| 53 |
HAEMOFILTRATION |
2 |
0.0105 |
| 54 |
BK POLYOMAVIRUS TEST POSITIVE |
1 |
0.0104 |
| 55 |
COOMBS NEGATIVE HAEMOLYTIC ANAEMIA |
2 |
0.0103 |
| 56 |
COMPUTERISED TOMOGRAM HEAD ABNORMAL |
1 |
0.0101 |
| 57 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
25 |
0.0097 |
| 58 |
COMPLEMENT FACTOR ABNORMAL |
1 |
0.0093 |
| 59 |
HYPERFERRITINAEMIA |
4 |
0.0093 |
| 60 |
LARYNGEAL SQUAMOUS CELL CARCINOMA |
1 |
0.0093 |
| 61 |
FLUID INTAKE RESTRICTION |
1 |
0.0091 |
| 62 |
TRANSFUSION RELATED COMPLICATION |
1 |
0.0090 |
| 63 |
HYPOGLOBULINAEMIA |
1 |
0.0088 |
| 64 |
GRAFT VERSUS HOST DISEASE IN EYE |
2 |
0.0087 |
| 65 |
ACHROMOBACTER INFECTION |
1 |
0.0083 |
| 66 |
MINIMAL RESIDUAL DISEASE |
4 |
0.0083 |
| 67 |
IMMOBILISATION PROLONGED |
1 |
0.0082 |
| 68 |
MEAN ARTERIAL PRESSURE DECREASED |
2 |
0.0079 |
| 69 |
KLEBSIELLA URINARY TRACT INFECTION |
2 |
0.0075 |
| 70 |
CYTOKINE INCREASED |
1 |
0.0074 |
| 71 |
PNEUMONIA ACINETOBACTER |
1 |
0.0073 |
| 72 |
CYTOKINE STORM |
5 |
0.0073 |
| 73 |
MUCOSAL HYPERTROPHY |
1 |
0.0068 |
| 74 |
ULTRASOUND LIVER ABNORMAL |
1 |
0.0066 |
| 75 |
LEUKAEMIA CUTIS |
1 |
0.0065 |
| 76 |
ALLOGENIC STEM CELL TRANSPLANTATION |
1 |
0.0063 |
| 77 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
47 |
0.0063 |
| 78 |
FUNGAL SEPSIS |
5 |
0.0060 |
| 79 |
ACUTE MACULAR NEURORETINOPATHY |
1 |
0.0058 |
| 80 |
INTERLEUKIN-2 RECEPTOR INCREASED |
1 |
0.0058 |
| 81 |
SOFT TISSUE SARCOMA |
2 |
0.0057 |
| 82 |
HYPOTHALAMO-PITUITARY DISORDER |
8 |
0.0055 |
| 83 |
HUMAN RHINOVIRUS TEST POSITIVE |
2 |
0.0054 |
| 84 |
CHEST TUBE INSERTION |
1 |
0.0053 |
| 85 |
MENINGOCOCCAL SEPSIS |
1 |
0.0053 |
| 86 |
INTENSIVE CARE UNIT ACQUIRED WEAKNESS |
2 |
0.0053 |
| 87 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
23 |
0.0052 |
| 88 |
BONE SARCOMA |
1 |
0.0052 |
| 89 |
CENTRAL NERVOUS SYSTEM LEUKAEMIA |
2 |
0.0051 |
| 90 |
OROPHARYNGEAL CANCER |
1 |
0.0048 |
| 91 |
GEOTRICHUM INFECTION |
1 |
0.0047 |
| 92 |
CLOSTRIDIUM BACTERAEMIA |
1 |
0.0047 |
| 93 |
UPPER MOTOR NEURONE LESION |
1 |
0.0045 |
| 94 |
SERUM FERRITIN INCREASED |
24 |
0.0045 |
| 95 |
MYELOPROLIFERATIVE NEOPLASM |
3 |
0.0045 |
| 96 |
MYELODYSPLASTIC SYNDROME |
65 |
0.0045 |
| 97 |
EPILEPTIC ENCEPHALOPATHY |
1 |
0.0045 |
| 98 |
SHUNT INFECTION |
1 |
0.0044 |
| 99 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
1 |
0.0043 |
| 100 |
CEREBRAL HYPOPERFUSION |
2 |
0.0043 |
| 101 |
ABSENCE OF IMMEDIATE TREATMENT RESPONSE |
1 |
0.0042 |
| 102 |
PILONIDAL DISEASE |
1 |
0.0042 |
| 103 |
BLOOD URIC ACID DECREASED |
2 |
0.0041 |
| 104 |
B-CELL TYPE ACUTE LEUKAEMIA |
3 |
0.0041 |
| 105 |
CHRONIC GRAFT VERSUS HOST DISEASE ORAL |
1 |
0.0041 |
| 106 |
ANGIOCENTRIC LYMPHOMA |
2 |
0.0041 |
| 107 |
DYSCALCULIA |
1 |
0.0040 |
| 108 |
VITAMIN B1 DECREASED |
1 |
0.0040 |
| 109 |
LEUKAEMIC INFILTRATION EXTRAMEDULLARY |
1 |
0.0039 |
| 110 |
ENTEROCOCCAL BACTERAEMIA |
4 |
0.0038 |
| 111 |
SINUSITIS FUNGAL |
3 |
0.0037 |
| 112 |
LIMBIC ENCEPHALITIS |
1 |
0.0036 |
| 113 |
REPETITIVE SPEECH |
2 |
0.0036 |
| 114 |
METASTASES TO MENINGES |
8 |
0.0035 |
| 115 |
BLOOD FIBRINOGEN DECREASED |
4 |
0.0035 |
| 116 |
HAEMATOMA INFECTION |
2 |
0.0035 |
| 117 |
POSTURAL TREMOR |
1 |
0.0034 |
| 118 |
FUNGAL ENDOCARDITIS |
1 |
0.0033 |
| 119 |
ALANINE AMINOTRANSFERASE ABNORMAL |
7 |
0.0033 |
| 120 |
PARAINFLUENZAE VIRUS INFECTION |
5 |
0.0033 |
| 121 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
9 |
0.0032 |
| 122 |
FUNGAEMIA |
5 |
0.0032 |
| 123 |
PHYSICAL DECONDITIONING |
8 |
0.0031 |
| 124 |
CENTRAL HYPOTHYROIDISM |
1 |
0.0030 |
| 125 |
TUMOUR FLARE |
2 |
0.0029 |
| 126 |
CHOLANGITIS SCLEROSING |
6 |
0.0029 |
| 127 |
NEUROENDOCRINE CARCINOMA |
2 |
0.0029 |
| 128 |
BASAL CELL CARCINOMA |
45 |
0.0029 |
| 129 |
LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION |
1 |
0.0029 |
| 130 |
ANOXIA |
1 |
0.0028 |
| 131 |
CHYLOTHORAX |
2 |
0.0028 |
| 132 |
TIME PERCEPTION ALTERED |
1 |
0.0028 |
| 133 |
CEREBRAL MASS EFFECT |
1 |
0.0028 |
| 134 |
MIXED ANXIETY AND DEPRESSIVE DISORDER |
1 |
0.0027 |
| 135 |
MUCORMYCOSIS |
7 |
0.0027 |
| 136 |
HERPES SIMPLEX REACTIVATION |
1 |
0.0026 |
| 137 |
SQUAMOUS CELL CARCINOMA OF LUNG |
2 |
0.0026 |
| 138 |
LOWER RESPIRATORY TRACT INFECTION FUNGAL |
1 |
0.0026 |
| 139 |
METASTATIC LYMPHOMA |
1 |
0.0026 |
| 140 |
DISSEMINATED MUCORMYCOSIS |
1 |
0.0025 |
| 141 |
CYTOPENIA |
31 |
0.0025 |
| 142 |
DEPENDENCE ON RESPIRATOR |
1 |
0.0025 |
| 143 |
TONSIL CANCER |
2 |
0.0025 |
| 144 |
TRANSPLANTATION COMPLICATION |
1 |
0.0024 |
| 145 |
BLOOD PRODUCT TRANSFUSION DEPENDENT |
1 |
0.0024 |
| 146 |
PERIPHERAL ARTERY ANEURYSM |
1 |
0.0024 |
| 147 |
MALIGNANT PLEURAL EFFUSION |
4 |
0.0024 |
| 148 |
POLYSEROSITIS |
1 |
0.0023 |
| 149 |
URINARY TRACT INFECTION STAPHYLOCOCCAL |
1 |
0.0023 |
| 150 |
SARCOPENIA |
1 |
0.0023 |
| 151 |
VASOCONSTRICTION |
2 |
0.0023 |
| 152 |
ENCEPHALITIS CYTOMEGALOVIRUS |
1 |
0.0023 |
| 153 |
HYPOGAMMAGLOBULINAEMIA |
15 |
0.0023 |
| 154 |
DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT |
5 |
0.0023 |
| 155 |
FACIAL NERVE DISORDER |
1 |
0.0023 |
| 156 |
MENINGOENCEPHALITIS HERPETIC |
1 |
0.0022 |
| 157 |
PERINEAL ABSCESS |
1 |
0.0022 |
| 158 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
2 |
0.0022 |
| 159 |
ENCEPHALOPATHY |
53 |
0.0022 |
| 160 |
PANCREATITIS HAEMORRHAGIC |
1 |
0.0022 |
| 161 |
DISSEMINATED ASPERGILLOSIS |
1 |
0.0021 |
| 162 |
SARS-COV-2 ANTIBODY TEST NEGATIVE |
1 |
0.0021 |
| 163 |
BLAST CELLS PRESENT |
1 |
0.0021 |
| 164 |
STEROID WITHDRAWAL SYNDROME |
2 |
0.0020 |
| 165 |
PERIORBITAL CELLULITIS |
1 |
0.0019 |
| 166 |
BACTERIAL SEPSIS |
6 |
0.0018 |
| 167 |
GASTROENTERITIS ESCHERICHIA COLI |
1 |
0.0018 |
| 168 |
OXYGEN THERAPY |
3 |
0.0018 |
| 169 |
DYSGRAPHIA |
12 |
0.0018 |
| 170 |
INTERLEUKIN LEVEL INCREASED |
1 |
0.0018 |
| 171 |
CYTOMEGALOVIRUS VIRAEMIA |
8 |
0.0018 |
| 172 |
BRAIN SCAN ABNORMAL |
1 |
0.0018 |
| 173 |
INFECTION REACTIVATION |
2 |
0.0017 |
| 174 |
CENTRAL NERVOUS SYSTEM INFECTION |
2 |
0.0017 |
| 175 |
PLEOCYTOSIS |
1 |
0.0017 |
| 176 |
SYSTEMIC MYCOSIS |
2 |
0.0017 |
| 177 |
ESCHERICHIA BACTERAEMIA |
4 |
0.0017 |
| 178 |
PNEUMOCOCCAL INFECTION |
1 |
0.0017 |
| 179 |
CAMPYLOBACTER GASTROENTERITIS |
1 |
0.0017 |
| 180 |
ACIDOSIS HYPERCHLORAEMIC |
1 |
0.0017 |
| 181 |
LYMPHATIC DISORDER |
1 |
0.0017 |
| 182 |
AGRAPHIA |
1 |
0.0017 |
| 183 |
PNEUMOCYSTIS JIROVECII INFECTION |
2 |
0.0017 |
| 184 |
URINARY TRACT INFECTION PSEUDOMONAL |
1 |
0.0017 |
| 185 |
BRAIN OEDEMA |
21 |
0.0017 |
| 186 |
SECONDARY IMMUNODEFICIENCY |
2 |
0.0016 |
| 187 |
SOFT TISSUE INFECTION |
3 |
0.0016 |
| 188 |
HUMAN HERPESVIRUS 6 INFECTION |
3 |
0.0016 |
| 189 |
HYPERCHLORAEMIA |
1 |
0.0016 |
| 190 |
RESTING TREMOR |
1 |
0.0015 |
| 191 |
VASCULAR DEVICE INFECTION |
7 |
0.0015 |
| 192 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
1 |
0.0015 |
| 193 |
FASCIITIS |
1 |
0.0015 |
| 194 |
APHASIA |
45 |
0.0015 |
| 195 |
TUMOUR LYSIS SYNDROME |
13 |
0.0015 |
| 196 |
MARROW HYPERPLASIA |
1 |
0.0015 |
| 197 |
CENTRAL NERVOUS SYSTEM LYMPHOMA |
2 |
0.0015 |
| 198 |
FUSARIUM INFECTION |
1 |
0.0014 |
| 199 |
FLUID IMBALANCE |
1 |
0.0014 |
| 200 |
NEUTROPENIC SEPSIS |
10 |
0.0014 |
| 201 |
BLADDER TRANSITIONAL CELL CARCINOMA |
2 |
0.0014 |
| 202 |
PERFORATED ULCER |
1 |
0.0013 |
| 203 |
MYOPERICARDITIS |
1 |
0.0013 |
| 204 |
CRITICAL ILLNESS |
1 |
0.0013 |
| 205 |
FEBRILE NEUTROPENIA |
85 |
0.0013 |
| 206 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
36 |
0.0013 |
| 207 |
VITAMIN B12 INCREASED |
1 |
0.0013 |
| 208 |
OXYGEN CONSUMPTION INCREASED |
3 |
0.0013 |
| 209 |
HAEMOPERITONEUM |
1 |
0.0012 |
| 210 |
PERFORATION |
1 |
0.0012 |
| 211 |
HYPOXIA |
43 |
0.0012 |
| 212 |
SPLENIC RUPTURE |
2 |
0.0012 |
| 213 |
HYPERVOLAEMIA |
6 |
0.0012 |
| 214 |
SYSTEMIC CANDIDA |
3 |
0.0012 |
| 215 |
BACTERAEMIA |
14 |
0.0012 |
| 216 |
FEBRILE BONE MARROW APLASIA |
5 |
0.0012 |
| 217 |
HYPERBILIRUBINAEMIA |
12 |
0.0012 |
| 218 |
INTESTINAL PERFORATION |
13 |
0.0012 |
| 219 |
PULMONARY CAVITATION |
1 |
0.0011 |
| 220 |
INTESTINAL PSEUDO-OBSTRUCTION |
1 |
0.0011 |
| 221 |
HYPERLEUKOCYTOSIS |
1 |
0.0011 |
| 222 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 223 |
SINUS NODE DYSFUNCTION |
2 |
0.0011 |
| 224 |
ACUTE MYELOID LEUKAEMIA |
17 |
0.0011 |
| 225 |
PNEUMONIA KLEBSIELLA |
2 |
0.0011 |
| 226 |
PNEUMOPERITONEUM |
2 |
0.0011 |
| 227 |
INTRACRANIAL MASS |
1 |
0.0011 |
| 228 |
KLEBSIELLA BACTERAEMIA |
1 |
0.0011 |
| 229 |
NEUROLOGICAL SYMPTOM |
6 |
0.0010 |
| 230 |
NEUTROPENIC INFECTION |
1 |
0.0010 |
| 231 |
ACTINOMYCOSIS |
1 |
0.0010 |
| 232 |
ESCHERICHIA SEPSIS |
3 |
0.0010 |
| 233 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 234 |
RHINOVIRUS INFECTION |
4 |
0.0010 |
| 235 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 236 |
BLOOD CULTURE POSITIVE |
3 |
0.0010 |
| 237 |
DUODENAL ULCER |
7 |
0.0010 |
| 238 |
AUTONOMIC NEUROPATHY |
1 |
0.0010 |
| 239 |
PANCYTOPENIA |
55 |
0.0010 |
| 240 |
HYPERURICAEMIA |
4 |
0.0010 |
| 241 |
DISEASE PROGRESSION |
115 |
0.0010 |
| 242 |
DIVERTICULAR PERFORATION |
2 |
0.0010 |
| 243 |
NEUTROPENIC COLITIS |
2 |
0.0010 |
| 244 |
POSTICTAL STATE |
1 |
0.0010 |
| 245 |
SUBILEUS |
2 |
0.0010 |
| 246 |
LYMPHANGIOSIS CARCINOMATOSA |
1 |
0.0010 |
| 247 |
TACHYPNOEA |
13 |
0.0010 |
| 248 |
BLAST CELL COUNT INCREASED |
1 |
0.0010 |
| 249 |
CYTOGENETIC ANALYSIS ABNORMAL |
1 |
0.0010 |
| 250 |
POLYOMAVIRUS VIRAEMIA |
1 |
0.0009 |
| 251 |
SINUS BRADYCARDIA |
9 |
0.0009 |
| 252 |
STAPHYLOCOCCAL BACTERAEMIA |
4 |
0.0009 |
| 253 |
STREPTOCOCCAL BACTERAEMIA |
1 |
0.0009 |
| 254 |
HAEMODYNAMIC INSTABILITY |
7 |
0.0009 |
| 255 |
GRAFT VERSUS HOST DISEASE IN SKIN |
2 |
0.0009 |
| 256 |
RETROPERITONEAL HAEMATOMA |
2 |
0.0009 |
| 257 |
BRONCHOPULMONARY ASPERGILLOSIS |
7 |
0.0009 |
| 258 |
HAEMOLYTIC ANAEMIA |
8 |
0.0009 |
| 259 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 260 |
SARCOMA |
1 |
0.0009 |
| 261 |
GASTROINTESTINAL CARCINOMA |
8 |
0.0009 |
| 262 |
PUPILS UNEQUAL |
1 |
0.0009 |
| 263 |
PANCREATITIS NECROTISING |
2 |
0.0009 |
| 264 |
NEUROLOGICAL DECOMPENSATION |
2 |
0.0009 |
| 265 |
ISCHAEMIC CEREBRAL INFARCTION |
1 |
0.0009 |
| 266 |
PROCALCITONIN INCREASED |
1 |
0.0009 |
| 267 |
HYPORESPONSIVE TO STIMULI |
1 |
0.0009 |
| 268 |
INCONTINENCE |
9 |
0.0009 |
| 269 |
FEBRILE INFECTION |
1 |
0.0008 |
| 270 |
TRANSPLANT |
2 |
0.0008 |
| 271 |
LACUNAR INFARCTION |
2 |
0.0008 |
| 272 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 273 |
HAEMATOMA MUSCLE |
1 |
0.0008 |
| 274 |
CARDIAC DEATH |
1 |
0.0008 |
| 275 |
PHARYNGEAL HAEMORRHAGE |
1 |
0.0008 |
| 276 |
HYPERNATRAEMIA |
4 |
0.0008 |
| 277 |
STEM CELL TRANSPLANT |
2 |
0.0008 |
| 278 |
MENTAL STATUS CHANGES |
22 |
0.0008 |
| 279 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
3 |
0.0008 |
| 280 |
DELIRIUM |
27 |
0.0008 |
| 281 |
PLATELET TRANSFUSION |
1 |
0.0008 |
| 282 |
CARDIAC VENTRICULAR THROMBOSIS |
1 |
0.0008 |
| 283 |
TRANSITIONAL CELL CARCINOMA |
1 |
0.0008 |
| 284 |
ADJUSTMENT DISORDER |
1 |
0.0008 |
| 285 |
FOLLICULITIS |
8 |
0.0008 |
| 286 |
PNEUMONIA FUNGAL |
3 |
0.0008 |
| 287 |
TUMOUR PAIN |
1 |
0.0008 |
| 288 |
RADICULOPATHY |
2 |
0.0008 |
| 289 |
AZOTAEMIA |
3 |
0.0008 |
| 290 |
VULVOVAGINAL CANDIDIASIS |
1 |
0.0007 |
| 291 |
HAEMATOTOXICITY |
7 |
0.0007 |
| 292 |
RECURRENT CANCER |
3 |
0.0007 |
| 293 |
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 294 |
CARDIOVERSION |
1 |
0.0007 |
| 295 |
ENDOTRACHEAL INTUBATION |
2 |
0.0007 |
| 296 |
MYELITIS TRANSVERSE |
1 |
0.0007 |
| 297 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
1 |
0.0007 |
| 298 |
STATUS EPILEPTICUS |
8 |
0.0007 |
| 299 |
NEUROENDOCRINE TUMOUR |
1 |
0.0007 |
| 300 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 301 |
TRACHEOSTOMY |
1 |
0.0007 |
| 302 |
PELVIC VENOUS THROMBOSIS |
1 |
0.0007 |
| 303 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 304 |
GRAFT VERSUS HOST DISEASE |
5 |
0.0007 |
| 305 |
PARAPLEGIA |
2 |
0.0007 |
| 306 |
ENTEROCOLITIS |
4 |
0.0007 |
| 307 |
FINE MOTOR SKILL DYSFUNCTION |
2 |
0.0007 |
| 308 |
MUTISM |
1 |
0.0007 |
| 309 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 310 |
CARDIAC FIBRILLATION |
1 |
0.0007 |
| 311 |
COVID-19 PNEUMONIA |
8 |
0.0007 |
| 312 |
BRAIN HERNIATION |
2 |
0.0007 |
| 313 |
STEROID DIABETES |
1 |
0.0007 |
| 314 |
SUPERINFECTION |
1 |
0.0007 |
| 315 |
HYPERCAPNIA |
2 |
0.0007 |
| 316 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
1 |
0.0007 |
| 317 |
ACIDOSIS |
5 |
0.0007 |
| 318 |
PALLIATIVE CARE |
1 |
0.0007 |
| 319 |
BRAIN DEATH |
2 |
0.0006 |
| 320 |
MYELITIS |
1 |
0.0006 |
| 321 |
ELECTROENCEPHALOGRAM ABNORMAL |
2 |
0.0006 |
| 322 |
CARDIAC TAMPONADE |
3 |
0.0006 |
| 323 |
SEPTIC SHOCK |
27 |
0.0006 |
| 324 |
QUADRIPARESIS |
1 |
0.0006 |
| 325 |
CYTOMEGALOVIRUS INFECTION |
10 |
0.0006 |
| 326 |
MALIGNANT MELANOMA |
8 |
0.0006 |
| 327 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 328 |
KLEBSIELLA INFECTION |
3 |
0.0006 |
| 329 |
HEPATORENAL SYNDROME |
1 |
0.0006 |
| 330 |
CLOSTRIDIAL INFECTION |
2 |
0.0006 |
| 331 |
BONE MARROW FAILURE |
12 |
0.0006 |
| 332 |
SEIZURE LIKE PHENOMENA |
1 |
0.0006 |
| 333 |
ENDOCARDITIS |
3 |
0.0006 |
| 334 |
CEREBRAL ISCHAEMIA |
3 |
0.0006 |
| 335 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
23 |
0.0006 |
| 336 |
SERUM FERRITIN DECREASED |
1 |
0.0006 |
| 337 |
TREATMENT DELAYED |
1 |
0.0006 |
| 338 |
TACHYCARDIA |
51 |
0.0006 |
| 339 |
EXTREMITY NECROSIS |
1 |
0.0006 |
| 340 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 341 |
BLOOD LACTIC ACID INCREASED |
3 |
0.0006 |
| 342 |
SPINAL OSTEOARTHRITIS |
5 |
0.0006 |
| 343 |
DISSEMINATED INTRAVASCULAR COAGULATION |
8 |
0.0006 |
| 344 |
NECROTISING FASCIITIS |
2 |
0.0006 |
| 345 |
LYMPHOCYTE COUNT DECREASED |
10 |
0.0006 |
| 346 |
TERMINAL INSOMNIA |
1 |
0.0006 |
| 347 |
CYTOMEGALOVIRUS TEST POSITIVE |
1 |
0.0006 |
| 348 |
CEREBRAL VENOUS THROMBOSIS |
1 |
0.0006 |
| 349 |
HYPOTENSION |
110 |
0.0005 |
| 350 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 351 |
CEREBRAL DISORDER |
4 |
0.0005 |
| 352 |
CATHETER PLACEMENT |
1 |
0.0005 |
| 353 |
SMALL INTESTINAL PERFORATION |
1 |
0.0005 |
| 354 |
BONE MARROW TRANSPLANT |
1 |
0.0005 |
| 355 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 356 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
5 |
0.0005 |
| 357 |
LYMPHADENOPATHY MEDIASTINAL |
1 |
0.0005 |
| 358 |
LYMPHOMA |
8 |
0.0005 |
| 359 |
ATELECTASIS |
5 |
0.0005 |
| 360 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 361 |
EARLY SATIETY |
1 |
0.0005 |
| 362 |
CARDIOPULMONARY FAILURE |
2 |
0.0005 |
| 363 |
THERAPY PARTIAL RESPONDER |
8 |
0.0005 |
| 364 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
1 |
0.0005 |
| 365 |
ABDOMINAL WALL HAEMATOMA |
1 |
0.0005 |
| 366 |
DIPLEGIA |
1 |
0.0005 |
| 367 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
8 |
0.0005 |
| 368 |
UNRESPONSIVE TO STIMULI |
13 |
0.0005 |
| 369 |
EMPYEMA |
1 |
0.0005 |
| 370 |
QUADRIPLEGIA |
1 |
0.0005 |
| 371 |
PULSELESS ELECTRICAL ACTIVITY |
2 |
0.0005 |
| 372 |
SHOCK |
11 |
0.0005 |
| 373 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 374 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
1 |
0.0005 |
| 375 |
FACIAL PARALYSIS |
4 |
0.0005 |
| 376 |
LYMPHOCYTOSIS |
1 |
0.0005 |
| 377 |
ASPERGILLUS INFECTION |
3 |
0.0005 |
| 378 |
INFECTION SUSCEPTIBILITY INCREASED |
1 |
0.0005 |
| 379 |
CEREBELLAR SYNDROME |
1 |
0.0005 |
| 380 |
ENDOMETRIAL CANCER |
1 |
0.0005 |
| 381 |
BLOOD CREATINE INCREASED |
2 |
0.0005 |
| 382 |
URINARY RETENTION |
15 |
0.0004 |
| 383 |
PARESIS |
1 |
0.0004 |
| 384 |
LARGE INTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 385 |
DISEASE COMPLICATION |
2 |
0.0004 |
| 386 |
NEOPLASM |
5 |
0.0004 |
| 387 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 388 |
AGRANULOCYTOSIS |
8 |
0.0004 |
| 389 |
HEPATIC ENCEPHALOPATHY |
4 |
0.0004 |
| 390 |
PULSE ABSENT |
2 |
0.0004 |
| 391 |
WEIGHT ABNORMAL |
1 |
0.0004 |
| 392 |
ACUTE RESPIRATORY FAILURE |
8 |
0.0004 |
| 393 |
ASPARTATE AMINOTRANSFERASE INCREASED |
22 |
0.0004 |
| 394 |
ENTEROCOCCAL INFECTION |
2 |
0.0004 |
| 395 |
GUILLAIN-BARRE SYNDROME |
2 |
0.0004 |
| 396 |
HEMIPARESIS |
7 |
0.0004 |
| 397 |
NEUTROPENIA |
56 |
0.0004 |
| 398 |
INFUSION RELATED REACTION |
27 |
0.0004 |
| 399 |
RETROPERITONEAL HAEMORRHAGE |
1 |
0.0004 |
| 400 |
CONFUSIONAL STATE |
65 |
0.0004 |
| 401 |
VENOOCCLUSIVE DISEASE |
1 |
0.0004 |
| 402 |
PLATELET DISORDER |
1 |
0.0004 |
| 403 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 404 |
TOXIC EPIDERMAL NECROLYSIS |
6 |
0.0004 |
| 405 |
HAEMORRHAGE URINARY TRACT |
1 |
0.0004 |
| 406 |
ISCHAEMIC STROKE |
7 |
0.0004 |
| 407 |
ANGLE CLOSURE GLAUCOMA |
1 |
0.0004 |
| 408 |
TRISMUS |
2 |
0.0004 |
| 409 |
INFECTION |
56 |
0.0004 |
| 410 |
APNOEA |
3 |
0.0004 |
| 411 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 412 |
FAILURE TO THRIVE |
2 |
0.0004 |
| 413 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 414 |
LUNG OPACITY |
1 |
0.0004 |
| 415 |
CLOSTRIDIUM DIFFICILE COLITIS |
4 |
0.0004 |
| 416 |
SEPSIS |
41 |
0.0004 |
| 417 |
ABNORMAL FAECES |
3 |
0.0004 |
| 418 |
CLONUS |
1 |
0.0004 |
| 419 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 420 |
ESCHERICHIA INFECTION |
3 |
0.0004 |
| 421 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
1 |
0.0004 |
| 422 |
SECOND PRIMARY MALIGNANCY |
3 |
0.0004 |
| 423 |
INTRACRANIAL PRESSURE INCREASED |
2 |
0.0004 |
| 424 |
PYREXIA |
124 |
0.0004 |
| 425 |
C-REACTIVE PROTEIN INCREASED |
13 |
0.0004 |
| 426 |
CEREBRAL THROMBOSIS |
1 |
0.0004 |
| 427 |
NERVOUS SYSTEM DISORDER |
11 |
0.0004 |
| 428 |
HAEMOTHORAX |
1 |
0.0003 |
| 429 |
HYPERKALAEMIA |
12 |
0.0003 |
| 430 |
HYPONATRAEMIA |
19 |
0.0003 |
| 431 |
ODYNOPHAGIA |
2 |
0.0003 |
| 432 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 433 |
PLATELET COUNT ABNORMAL |
2 |
0.0003 |
| 434 |
PLEURAL EFFUSION |
20 |
0.0003 |
| 435 |
DISORIENTATION |
13 |
0.0003 |
| 436 |
DYSAESTHESIA |
1 |
0.0003 |
| 437 |
COGNITIVE DISORDER |
15 |
0.0003 |
| 438 |
ACUTE KIDNEY INJURY |
49 |
0.0003 |
| 439 |
EPSTEIN-BARR VIRUS INFECTION |
2 |
0.0003 |
| 440 |
SQUAMOUS CELL CARCINOMA |
3 |
0.0003 |
| 441 |
RESPIRATORY FAILURE |
23 |
0.0003 |
| 442 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 443 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 444 |
TREMOR |
52 |
0.0003 |
| 445 |
AGITATION |
23 |
0.0003 |
| 446 |
STUPOR |
1 |
0.0003 |
| 447 |
THROMBOTIC MICROANGIOPATHY |
3 |
0.0003 |
| 448 |
HERPES SIMPLEX |
2 |
0.0003 |
| 449 |
BRADYPHRENIA |
2 |
0.0003 |
| 450 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 451 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 452 |
CEREBRAL HAEMATOMA |
1 |
0.0003 |
| 453 |
METASTASES TO SPINE |
1 |
0.0003 |
| 454 |
CANDIDA INFECTION |
5 |
0.0003 |
| 455 |
THROMBOCYTOPENIA |
33 |
0.0003 |
| 456 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 457 |
NEUTROPHIL COUNT DECREASED |
12 |
0.0003 |
| 458 |
B-CELL LYMPHOMA |
1 |
0.0003 |
| 459 |
MOTOR DYSFUNCTION |
3 |
0.0003 |
| 460 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
3 |
0.0003 |
| 461 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
1 |
0.0003 |
| 462 |
WOUND COMPLICATION |
1 |
0.0003 |
| 463 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
1 |
0.0003 |
| 464 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 465 |
DROOLING |
2 |
0.0003 |
| 466 |
ENCEPHALITIS |
2 |
0.0003 |
| 467 |
GRANULOMA |
1 |
0.0003 |
| 468 |
HYPOPNOEA |
1 |
0.0003 |
| 469 |
LYMPHOPENIA |
4 |
0.0003 |
| 470 |
FACIAL PARESIS |
1 |
0.0003 |
| 471 |
PNEUMONIA ASPIRATION |
7 |
0.0003 |
| 472 |
FACIAL BONES FRACTURE |
1 |
0.0003 |
| 473 |
SEIZURE |
32 |
0.0003 |
| 474 |
IMMUNE-MEDIATED ENTEROCOLITIS |
1 |
0.0003 |
| 475 |
ARTHROPOD BITE |
2 |
0.0003 |
| 476 |
LEUKOENCEPHALOPATHY |
1 |
0.0003 |
| 477 |
MALNUTRITION |
3 |
0.0003 |
| 478 |
CHEMOTHERAPY |
1 |
0.0003 |
| 479 |
COLITIS |
10 |
0.0003 |
| 480 |
HAEMATURIA |
9 |
0.0003 |
| 481 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 482 |
COMMUNICATION DISORDER |
1 |
0.0003 |
| 483 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 484 |
DEATH |
224 |
0.0003 |
| 485 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 486 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 487 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 488 |
MUSCLE HAEMORRHAGE |
1 |
0.0002 |
| 489 |
MENTAL IMPAIRMENT |
6 |
0.0002 |
| 490 |
BRADYCARDIA |
13 |
0.0002 |
| 491 |
BODY TEMPERATURE INCREASED |
5 |
0.0002 |
| 492 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
2 |
0.0002 |
| 493 |
VENTRICULAR TACHYCARDIA |
4 |
0.0002 |
| 494 |
GENERALISED TONIC-CLONIC SEIZURE |
4 |
0.0002 |
| 495 |
ILEUS |
3 |
0.0002 |
| 496 |
GASTROINTESTINAL PERFORATION |
1 |
0.0002 |
| 497 |
COAGULOPATHY |
4 |
0.0002 |
| 498 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
1 |
0.0002 |
| 499 |
HYPERPYREXIA |
1 |
0.0002 |
| 500 |
ABSCESS LIMB |
1 |
0.0002 |
| 501 |
PRODUCT CONTAINER ISSUE |
2 |
0.0002 |
| 502 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 503 |
TOOTH INJURY |
1 |
0.0002 |
| 504 |
MUCOSAL INFLAMMATION |
6 |
0.0002 |
| 505 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
4 |
0.0002 |
| 506 |
LETHARGY |
13 |
0.0002 |
| 507 |
ATRIAL FIBRILLATION |
22 |
0.0002 |
| 508 |
RESPIRATORY RATE INCREASED |
2 |
0.0002 |
| 509 |
CARDIOTOXICITY |
2 |
0.0002 |
| 510 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 511 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
1 |
0.0002 |
| 512 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 513 |
ISCHAEMIA |
1 |
0.0002 |
| 514 |
DIVERTICULITIS |
6 |
0.0002 |
| 515 |
PERSONALITY CHANGE |
2 |
0.0002 |
| 516 |
BACTERIAL INFECTION |
4 |
0.0002 |
| 517 |
BLOOD SODIUM DECREASED |
4 |
0.0002 |
| 518 |
LEUKAEMIA |
2 |
0.0002 |
| 519 |
ALANINE AMINOTRANSFERASE INCREASED |
13 |
0.0002 |
| 520 |
SUBDURAL HAEMATOMA |
3 |
0.0002 |
| 521 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 522 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 523 |
RENAL CELL CARCINOMA |
1 |
0.0002 |
| 524 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 525 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 526 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 527 |
PLATELET COUNT DECREASED |
21 |
0.0002 |
| 528 |
MEMORY IMPAIRMENT |
27 |
0.0002 |
| 529 |
CHILLS |
23 |
0.0002 |
| 530 |
AMMONIA INCREASED |
1 |
0.0002 |
| 531 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 532 |
ARRHYTHMIA |
9 |
0.0002 |
| 533 |
HALLUCINATION, VISUAL |
4 |
0.0002 |
| 534 |
COMA |
9 |
0.0002 |
| 535 |
LIVER FUNCTION TEST INCREASED |
4 |
0.0002 |
| 536 |
ANAL ABSCESS |
1 |
0.0002 |
| 537 |
LACTIC ACIDOSIS |
6 |
0.0002 |
| 538 |
HYDROCEPHALUS |
1 |
0.0002 |
| 539 |
WOUND INFECTION |
2 |
0.0002 |
| 540 |
ASPIRATION |
2 |
0.0002 |
| 541 |
COVID-19 |
32 |
0.0002 |
| 542 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 543 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0002 |
| 544 |
PULMONARY ALVEOLAR HAEMORRHAGE |
1 |
0.0002 |
| 545 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 546 |
REBOUND EFFECT |
2 |
0.0002 |
| 547 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 548 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 549 |
NEOPLASM PROGRESSION |
6 |
0.0002 |
| 550 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 551 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 552 |
SPLENOMEGALY |
2 |
0.0002 |
| 553 |
BLOOD TRIGLYCERIDES INCREASED |
3 |
0.0002 |
| 554 |
DISEASE RECURRENCE |
8 |
0.0002 |
| 555 |
CHOLECYSTITIS |
2 |
0.0002 |
| 556 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 557 |
POLYNEUROPATHY |
2 |
0.0002 |
| 558 |
HEPATITIS B |
1 |
0.0002 |
| 559 |
HYPERGLYCAEMIA |
6 |
0.0002 |
| 560 |
OLIGURIA |
1 |
0.0002 |
| 561 |
THERAPY NON-RESPONDER |
7 |
0.0002 |
| 562 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 563 |
MENINGITIS |
1 |
0.0001 |
| 564 |
GAIT INABILITY |
5 |
0.0001 |
| 565 |
POST-TRAUMATIC STRESS DISORDER |
1 |
0.0001 |
| 566 |
BREAST MASS |
1 |
0.0001 |
| 567 |
ULCER HAEMORRHAGE |
1 |
0.0001 |
| 568 |
INFARCTION |
1 |
0.0001 |
| 569 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 570 |
UNEVALUABLE EVENT |
11 |
0.0001 |
| 571 |
JOINT EFFUSION |
1 |
0.0001 |
| 572 |
RESPIRATORY DISTRESS |
4 |
0.0001 |
| 573 |
SOMNOLENCE |
29 |
0.0001 |
| 574 |
OXYGEN SATURATION DECREASED |
8 |
0.0001 |
| 575 |
LYMPHADENOPATHY |
5 |
0.0001 |
| 576 |
DIALYSIS |
2 |
0.0001 |
| 577 |
THERMAL BURN |
1 |
0.0001 |
| 578 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 579 |
PANIC REACTION |
1 |
0.0001 |
| 580 |
ASCITES |
4 |
0.0001 |
| 581 |
MYALGIA |
23 |
0.0001 |
| 582 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 583 |
IMMUNODEFICIENCY |
2 |
0.0001 |
| 584 |
HAEMORRHAGE INTRACRANIAL |
2 |
0.0001 |
| 585 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 586 |
HEPATIC FAILURE |
4 |
0.0001 |
| 587 |
HYPERTHERMIA |
1 |
0.0001 |
| 588 |
EPILEPSY |
4 |
0.0001 |
| 589 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 590 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 591 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 592 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 593 |
DECUBITUS ULCER |
1 |
0.0001 |
| 594 |
LUNG NEOPLASM MALIGNANT |
5 |
0.0001 |
| 595 |
CARDIAC ARREST |
10 |
0.0001 |
| 596 |
GENERAL PHYSICAL HEALTH DETERIORATION |
14 |
0.0001 |
| 597 |
PSYCHOMOTOR HYPERACTIVITY |
2 |
0.0001 |
| 598 |
HEMIPLEGIA |
1 |
0.0001 |
| 599 |
VIRAL INFECTION |
4 |
0.0001 |
| 600 |
FUNGAL INFECTION |
4 |
0.0001 |
| 601 |
CARDIO-RESPIRATORY ARREST |
5 |
0.0001 |
| 602 |
ATRIAL SEPTAL DEFECT |
1 |
0.0001 |
| 603 |
CIRCULATORY COLLAPSE |
2 |
0.0001 |
| 604 |
DECREASED APPETITE |
27 |
0.0001 |
| 605 |
MUSCULOSKELETAL DISCOMFORT |
2 |
0.0001 |
| 606 |
ANURIA |
1 |
0.0001 |
| 607 |
MYOPATHY |
1 |
0.0001 |
| 608 |
FATIGUE |
90 |
0.0001 |
| 609 |
ILL-DEFINED DISORDER |
7 |
0.0001 |
| 610 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 611 |
ORTHOSTATIC HYPOTENSION |
2 |
0.0001 |
| 612 |
IMMUNOSUPPRESSION |
1 |
0.0001 |
| 613 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 614 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 615 |
BLOOD BILIRUBIN INCREASED |
3 |
0.0001 |
| 616 |
OPTIC NEURITIS |
1 |
0.0001 |
| 617 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 618 |
UROSEPSIS |
1 |
0.0001 |
| 619 |
RENAL IMPAIRMENT |
9 |
0.0001 |
| 620 |
APPENDICITIS |
1 |
0.0001 |
| 621 |
HEPATIC CIRRHOSIS |
2 |
0.0001 |
| 622 |
DYSARTHRIA |
4 |
0.0001 |
| 623 |
DYSPHAGIA |
10 |
0.0001 |
| 624 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 625 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
5 |
0.0001 |
| 626 |
AFFECT LABILITY |
1 |
0.0001 |
| 627 |
INTENTIONAL PRODUCT USE ISSUE |
9 |
0.0001 |
| 628 |
ORAL HERPES |
2 |
0.0001 |
| 629 |
HEPATOMEGALY |
1 |
0.0001 |
| 630 |
ACUTE MYOCARDIAL INFARCTION |
3 |
0.0001 |
| 631 |
HOSPICE CARE |
1 |
0.0001 |
| 632 |
HYPOTONIA |
1 |
0.0001 |
| 633 |
AGGRESSION |
5 |
0.0001 |
| 634 |
BRAIN INJURY |
1 |
0.0001 |
| 635 |
LACRIMATION INCREASED |
3 |
0.0001 |
| 636 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 637 |
PERITONITIS BACTERIAL |
1 |
0.0001 |
| 638 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 639 |
HYPOTHERMIA |
1 |
0.0001 |
| 640 |
FLUID RETENTION |
5 |
0.0001 |
| 641 |
TRANSFUSION |
1 |
0.0001 |
| 642 |
SPEECH DISORDER |
5 |
0.0001 |
| 643 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 644 |
METABOLIC ACIDOSIS |
3 |
0.0001 |
| 645 |
HIP FRACTURE |
3 |
0.0001 |
| 646 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 647 |
CLOSTRIDIUM DIFFICILE INFECTION |
2 |
0.0001 |
| 648 |
STAPHYLOCOCCAL INFECTION |
3 |
0.0001 |
| 649 |
VENTRICULAR FIBRILLATION |
1 |
0.0001 |
| 650 |
TYPE 2 DIABETES MELLITUS |
3 |
0.0001 |
| 651 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 652 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 653 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 654 |
TREATMENT FAILURE |
7 |
0.0001 |
| 655 |
MYOCLONUS |
1 |
0.0001 |
| 656 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 657 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 658 |
PNEUMONIA |
27 |
0.0001 |
| 659 |
THYROID CANCER |
1 |
0.0001 |
| 660 |
WHITE BLOOD CELL COUNT DECREASED |
9 |
0.0001 |
| 661 |
MALAISE |
36 |
0.0001 |
| 662 |
CEREBRAL INFARCTION |
2 |
0.0001 |
| 663 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 664 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 665 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 666 |
ANAEMIA |
15 |
0.0001 |
| 667 |
LOSS OF CONSCIOUSNESS |
10 |
0.0001 |
| 668 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 669 |
INFLAMMATION |
4 |
0.0001 |
| 670 |
HAEMATOMA |
2 |
0.0001 |
| 671 |
DIPLOPIA |
2 |
0.0001 |
| 672 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 673 |
BLOOD PRESSURE DECREASED |
5 |
0.0001 |
| 674 |
NEOPLASM MALIGNANT |
5 |
0.0001 |
| 675 |
OEDEMA |
4 |
0.0001 |
| 676 |
BLINDNESS |
3 |
0.0001 |
| 677 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 678 |
SKIN LESION |
2 |
0.0001 |
| 679 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 680 |
MASS |
1 |
0.0001 |
| 681 |
SKIN REACTION |
1 |
0.0001 |
| 682 |
TARDIVE DYSKINESIA |
2 |
0.0001 |
| 683 |
HEPATOCELLULAR INJURY |
1 |
0.0001 |
| 684 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 685 |
SYNCOPE |
7 |
0.0001 |
| 686 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 687 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 688 |
FLUID OVERLOAD |
1 |
0.0001 |
| 689 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 690 |
CEREBROVASCULAR ACCIDENT |
11 |
0.0001 |
| 691 |
EMOTIONAL DISORDER |
2 |
0.0001 |
| 692 |
BRAIN FOG |
1 |
0.0001 |
| 693 |
PNEUMOTHORAX |
1 |
0.0001 |
| 694 |
ULCER |
1 |
0.0001 |
| 695 |
CYSTITIS |
2 |
0.0001 |
| 696 |
INFLUENZA |
7 |
0.0001 |
| 697 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 698 |
BLOOD POTASSIUM INCREASED |
1 |
0.0001 |
| 699 |
LEUKOPENIA |
3 |
0.0001 |
| 700 |
SKIN DISORDER |
2 |
0.0001 |
| 701 |
FACE OEDEMA |
1 |
0.0001 |
| 702 |
BALANCE DISORDER |
5 |
0.0001 |
| 703 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 704 |
DRUG ERUPTION |
1 |
0.0001 |
| 705 |
GASTROINTESTINAL DISORDER |
5 |
0.0001 |
| 706 |
ELECTROCARDIOGRAM QT PROLONGED |
2 |
0.0001 |
| 707 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 708 |
HEADACHE |
34 |
0.0001 |
| 709 |
THINKING ABNORMAL |
1 |
0.0001 |
| 710 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 711 |
MUSCULAR WEAKNESS |
6 |
0.0001 |
| 712 |
RENAL FAILURE |
7 |
0.0001 |
| 713 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 714 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 715 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 716 |
HYPERTENSION |
11 |
0.0001 |
| 717 |
ASTHENIA |
19 |
0.0001 |
| 718 |
SINUS DISORDER |
1 |
0.0001 |
| 719 |
CARDIAC FAILURE |
4 |
0.0000 |
| 720 |
HAEMOGLOBIN DECREASED |
5 |
0.0000 |
| 721 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 722 |
PERITONITIS |
1 |
0.0000 |
| 723 |
TOOTH LOSS |
1 |
0.0000 |
| 724 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 725 |
GAIT DISTURBANCE |
9 |
0.0000 |
| 726 |
RETCHING |
1 |
0.0000 |
| 727 |
HYPOACUSIS |
2 |
0.0000 |
| 728 |
SKIN CANCER |
1 |
0.0000 |
| 729 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 730 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
1 |
0.0000 |
| 731 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 732 |
MELAENA |
1 |
0.0000 |
| 733 |
STEVENS-JOHNSON SYNDROME |
1 |
0.0000 |
| 734 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 735 |
TOOTH DISORDER |
1 |
0.0000 |
| 736 |
HEPATOTOXICITY |
1 |
0.0000 |
| 737 |
ORAL PAIN |
1 |
0.0000 |
| 738 |
PARAESTHESIA |
7 |
0.0000 |
| 739 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 740 |
LOWER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 741 |
DRUG INEFFECTIVE |
57 |
0.0000 |
| 742 |
RENAL DISORDER |
2 |
0.0000 |
| 743 |
PULMONARY EMBOLISM |
4 |
0.0000 |
| 744 |
PRESYNCOPE |
1 |
0.0000 |
| 745 |
NEURALGIA |
1 |
0.0000 |
| 746 |
LUNG DISORDER |
2 |
0.0000 |
| 747 |
LIVER INJURY |
1 |
0.0000 |
| 748 |
DIARRHOEA |
26 |
0.0000 |
| 749 |
CELLULITIS |
2 |
0.0000 |
| 750 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 751 |
GASTRIC CANCER |
1 |
0.0000 |
| 752 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 753 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 754 |
HYPOPHAGIA |
1 |
0.0000 |
| 755 |
DRUG RESISTANCE |
1 |
0.0000 |
| 756 |
ILLNESS |
4 |
0.0000 |
| 757 |
SEDATION |
1 |
0.0000 |
| 758 |
JAUNDICE |
1 |
0.0000 |
| 759 |
DYSPNOEA |
21 |
0.0000 |
| 760 |
LIMB INJURY |
1 |
0.0000 |
| 761 |
PALLOR |
1 |
0.0000 |
| 762 |
NAUSEA |
29 |
0.0000 |
| 763 |
DEMENTIA |
1 |
0.0000 |
| 764 |
COUGH |
10 |
0.0000 |
| 765 |
TOXICITY TO VARIOUS AGENTS |
6 |
0.0000 |
| 766 |
EYE PAIN |
2 |
0.0000 |
| 767 |
PAIN IN JAW |
1 |
0.0000 |
| 768 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 769 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 770 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 771 |
HYPERSOMNIA |
1 |
0.0000 |
| 772 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 773 |
OFF LABEL USE |
30 |
0.0000 |
| 774 |
VOMITING |
16 |
0.0000 |
| 775 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 776 |
IRRITABILITY |
2 |
0.0000 |
| 777 |
STOMATITIS |
2 |
0.0000 |
| 778 |
DISCOMFORT |
2 |
0.0000 |
| 779 |
CHEST PAIN |
6 |
0.0000 |
| 780 |
HEAD INJURY |
1 |
0.0000 |
| 781 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 782 |
MOOD SWINGS |
1 |
0.0000 |
| 783 |
ARTHRALGIA |
13 |
0.0000 |
| 784 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 785 |
NIGHT SWEATS |
1 |
0.0000 |
| 786 |
HEART RATE INCREASED |
3 |
0.0000 |
| 787 |
LIP SWELLING |
1 |
0.0000 |
| 788 |
CONDITION AGGRAVATED |
9 |
0.0000 |
| 789 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 790 |
MALIGNANT NEOPLASM PROGRESSION |
3 |
0.0000 |
| 791 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 792 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 793 |
HEART RATE DECREASED |
1 |
0.0000 |
| 794 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 795 |
RESTLESSNESS |
1 |
0.0000 |
| 796 |
DYSURIA |
1 |
0.0000 |
| 797 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 798 |
WEIGHT DECREASED |
7 |
0.0000 |
| 799 |
PROSTATE CANCER |
2 |
0.0000 |
| 800 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 801 |
OEDEMA PERIPHERAL |
3 |
0.0000 |
| 802 |
FALL |
8 |
0.0000 |
| 803 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 804 |
ANGIOEDEMA |
1 |
0.0000 |
| 805 |
LIVER DISORDER |
1 |
0.0000 |
| 806 |
DEHYDRATION |
3 |
0.0000 |
| 807 |
COLITIS ULCERATIVE |
1 |
0.0000 |
| 808 |
THROAT IRRITATION |
1 |
0.0000 |
| 809 |
TINNITUS |
1 |
0.0000 |
| 810 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 811 |
SWELLING |
2 |
0.0000 |
| 812 |
COLORECTAL CANCER |
1 |
0.0000 |
| 813 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 814 |
RASH |
9 |
0.0000 |
| 815 |
FLUSHING |
2 |
0.0000 |
| 816 |
THERAPY CESSATION |
1 |
0.0000 |
| 817 |
DEPRESSED MOOD |
1 |
0.0000 |
| 818 |
RASH PRURITIC |
1 |
0.0000 |
| 819 |
CONSTIPATION |
4 |
0.0000 |
| 820 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 821 |
MEDICATION ERROR |
1 |
0.0000 |
| 822 |
FLATULENCE |
1 |
0.0000 |
| 823 |
HERPES ZOSTER |
1 |
0.0000 |
| 824 |
MYOCARDIAL INFARCTION |
3 |
0.0000 |
| 825 |
BONE PAIN |
1 |
0.0000 |
| 826 |
SURGERY |
1 |
0.0000 |
| 827 |
BLADDER CANCER |
1 |
0.0000 |
| 828 |
VERTIGO |
1 |
0.0000 |
| 829 |
PRODUCT USE IN UNAPPROVED INDICATION |
4 |
0.0000 |
| 830 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 831 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 832 |
AMNESIA |
1 |
0.0000 |
| 833 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 834 |
ANXIETY |
4 |
0.0000 |
| 835 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 836 |
MOBILITY DECREASED |
1 |
0.0000 |
| 837 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 838 |
EPISTAXIS |
1 |
0.0000 |
| 839 |
HYPOAESTHESIA |
2 |
0.0000 |
| 840 |
HALLUCINATION |
1 |
0.0000 |
| 841 |
DEPRESSION |
3 |
0.0000 |
| 842 |
INCORRECT DOSE ADMINISTERED |
3 |
0.0000 |
| 843 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 844 |
BACK PAIN |
3 |
0.0000 |
| 845 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 846 |
THROMBOSIS |
1 |
0.0000 |
| 847 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 848 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 849 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 850 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 851 |
ADVERSE EVENT |
1 |
0.0000 |
| 852 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 853 |
BREAST CANCER |
1 |
0.0000 |
| 854 |
CARDIAC DISORDER |
1 |
0.0000 |
| 855 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 856 |
CONTUSION |
1 |
0.0000 |
| 857 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 858 |
SINUSITIS |
1 |
0.0000 |
| 859 |
HAEMORRHAGE |
1 |
0.0000 |
| 860 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 861 |
FEELING ABNORMAL |
2 |
0.0000 |
| 862 |
JOINT SWELLING |
1 |
0.0000 |
| 863 |
PAIN |
5 |
0.0000 |
| 864 |
HYPERHIDROSIS |
1 |
0.0000 |
| 865 |
VISION BLURRED |
1 |
0.0000 |
| 866 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 867 |
DIZZINESS |
3 |
0.0000 |
| 868 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 869 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 870 |
MUSCLE SPASMS |
1 |
0.0000 |
| 871 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 872 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 873 |
PRURITUS |
2 |
0.0000 |
| 874 |
ALOPECIA |
1 |
0.0000 |
| 875 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 876 |
ERYTHEMA |
1 |
0.0000 |